EGFR nuclear import in gallbladder carcinoma: Nuclear phosphorylated EGFR upregulates iNOS expression and confers independent prognostic impact

Annals of Surgical Oncology

Volumn 19, Issue 2, 2012, Pages 443-454

  Li, Chien Feng ^a,b,c,d   Fang, Fu Ming ^e   Wang, Ju Ming ^f   Tzeng, Ching Cherng ^a   Tai, Hui Chun ^g   Wei, Yu Ching ^e   Li, Shau Hsuan ^e   Lee, Yuan Ting ^e   Wang, Yu Hui ^e,f   Yu, Shih Chen ^e   Shiue, Yow Ling ^b   Chu, Patrick Yu Wei ^c   Wang, Wen Ling ^f   Chen, Li Tzong ^c   Huang, Hsuan Ying ^e  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d SOUTHERN TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^e CHANG GUNG UNIVERSITY   (Taiwan)

^f NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^g CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; LUCIFERASE;

AGED; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER PROGNOSIS; CELLULAR DISTRIBUTION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME ASSAY; EXON; FEMALE; GALLBLADDER CARCINOMA; GENE TRANSLOCATION; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NUCLEAR IMPORT; PHOSPHORYLATION; PROTEIN EXPRESSION; TISSUE MICROARRAY;

ACTIVE TRANSPORT, CELL NUCLEUS; ADENOCARCINOMA; AGED; BLOTTING, WESTERN; CARCINOMA, PAPILLARY; CELL NUCLEUS; CHROMATIN IMMUNOPRECIPITATION; CYTOPLASM; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GALLBLADDER NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; LUCIFERASES; MALE; MUTATION; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHORYLATION; PROGNOSIS; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SURVIVAL RATE; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 84856674492     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1942-6     Document Type: Article

References (23)

1. HW Lo MC Hung 2006 Nuclear EGFR signaling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival Br J Cancer 94 2 184 188 16434982 10.1038/sj.bjc.6602941 1:CAS:528:DC%2BD28XmvVyntQ%3D%3D
2. SC Wang MC Hung 2009 Nuclear translocation of the epidermal growth factor receptor family membrane tyrosine kinase receptors Clin Cancer Res 15 21 6484 6489 19861462 10.1158/1078-0432.CCR-08-2813 1:CAS:528:DC%2BD1MXhtlCjsrnN
3. HW Lo W Xia Y Wei M Ali-Seyed SF Huang MC Hung 2005 Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer Cancer Res 65 1 338 348 15665312 1:CAS:528:DC%2BD2MXhvFalsA%3D%3D
4. I Hadzisejdic E Mustac N Jonjic M Petkovic B Grahovac 2010 Nuclear EGFR in ductal invasive breast cancer: correlation with cyclin-D1 and prognosis Mod Pathol 23 3 392 403 20062009 10.1038/modpathol.2009.166 1:CAS:528: DC%2BC3cXis1Sgu78%3D
5. A Psyrri Z Yu PM Weinberger, et al. 2005 Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis Clin Cancer Res 11 16 5856 5862 16115926 10.1158/1078-0432.CCR-05-0420 1:CAS:528:DC%2BD2MXos1Cjtbg%3D
6. W Xia Y Wei Y Du, et al. 2009 Nuclear expression of epidermal growth factor receptor is a novel prognostic value in patients with ovarian cancer Mol Carcinog 48 7 610 617 19058255 10.1002/mc.20504 1:CAS:528:DC%2BD1MXnvFGgtr0%3D
7. JM Wang CY Ko LC Chen WL Wang WC Chang 2006 Functional role of NF-IL6beta and its sumoylation and acetylation modifications in promoter activation of cyclooxygenase 2 gene Nucl Acids Res 34 1 217 231 16397300 10.1093/nar/gkj422 1:CAS:528:DC%2BD28Xmsl2mtw%3D%3D
8. HW Lo SC Hsu M Ali-Seyed, et al. 2005 Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway Cancer Cell 7 6 575 589 15950906 10.1016/j.ccr.2005.05.007 1:CAS:528:DC%2BD2MXlslCgsrc%3D
9. SH Li CF Li MT Sung, et al. 2007 Skp2 is an independent prognosticator of gallbladder carcinoma among p27(Kip1)-interacting cell cycle regulators: an immunohistochemical study of 62 cases by tissue microarray Mod Pathol 20 4 497 507 17384652 10.1038/modpathol.3800762 1:CAS:528:DC%2BD2sXjtlyltLw%3D
10. JS Reis-Filho F Milanezi S Carvalho, et al. 2005 Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis Breast Cancer Res 7 6 R1028 R1035 16280056 10.1186/bcr1341 1:CAS:528:DC%2BD2MXht1WmsrjF
11. JW Chang HP Liu MH Hsieh, et al. 2008 Increased epidermal growth factor receptor (EGFR) gene copy number is strongly associated with EGFR mutations and adenocarcinoma in non-small cell lung cancers: a chromogenic in situ hybridization study of 182 patients Lung Cancer 61 3 328 339 18304690 10.1016/j.lungcan.2008.01.009
12. H Asano S Toyooka M Tokumo, et al. 2006 Detection of EGFR gene mutation in lung cancer by mutant-enriched polymerase chain reaction assay Clin Cancer Res 12 1 43 48 16397022 10.1158/1078-0432.CCR-05-0934 1:CAS:528: DC%2BD28Xht1GrtQ%3D%3D
13. Y Fong YS Lin CP Liou CF Li CC Tzeng 2010 Chromosomal imbalances in lung adenocarcinomas with or without mutations in the epidermal growth factor receptor gene Respirology. 15 700 705 20409020 10.1111/j.1440-1843.2010.01746.x
14. SC Wang MC Hung 2005 Cytoplasmic/nuclear shuttling and tumor progression Ann NY Acad Sci 1059 11 15 16382038 10.1196/annals.1339.002 1:CAS:528: DC%2BD28XhvFGntrg%3D
15. N Hanada HW Lo CP Day Y Pan Y Nakajima MC Hung 2006 Co-regulation of B-Myb expression by E2F1 and EGF receptor Mol Carcinog 45 1 10 17 16299810 10.1002/mc.20147 1:CAS:528:DC%2BD28XntVSrug%3D%3D
16. LY Hung JT Tseng YC Lee, et al. 2008 Nuclear epidermal growth factor receptor (EGFR) interacts with signal transducer and activator of transcription 5 (STAT5) in activating Aurora-A gene expression Nucl Acids Res 36 13 4337 4351 18586824 10.1093/nar/gkn417 1:CAS:528:DC%2BD1cXptVCgsbY%3D
17. F Leone G Cavalloni Y Pignochino, et al. 2006 Somatic mutations of epidermal growth factor receptor in bile duct and gallbladder carcinoma Clin Cancer Res 12 6 1680 1685 16551849 10.1158/1078-0432.CCR-05-1692 1:CAS:528:DC%2BD28Xis1Cjsrc%3D
18. K Nakazawa Y Dobashi S Suzuki H Fujii Y Takeda A Ooi 2005 Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers J Pathol 206 3 356 365 15892172 10.1002/path.1779 1:CAS:528:DC%2BD2MXmvVartb0%3D
19. A Ooi S Suzuki K Nakazawa J Itakura I Imoto H Nakamura Y Dobashi 2009 Gene amplification of Myc and its coamplification with ERBB2 and EGFR in gallbladder adenocarcinoma Anticancer Res 29 1 19 26 19331129
20. W Pao V Miller M Zakowski, et al. 2004 EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib Proc Natl Acad Sci USA 101 36 13306 13311 15329413 10.1073/pnas.0405220101 1:CAS:528:DC%2BD2cXnvFems70%3D
21. K Dittmann C Mayer HP Rodemann 2010 Nuclear EGFR as novel therapeutic target: insights into nuclear translocation and function Strahlenther Onkol 186 1 1 6 20082181 10.1007/s00066-009-2026-4
22. HP Kim YK Yoon JW Kim, et al. 2009 Lapatinib, a dual EGFR and HER2 tyrosine kinase inhibitor, downregulates thymidylate synthase by inhibiting the nuclear translocation of EGFR and HER2 PLoS One 4 6 e5933 19529774 10.1371/journal.pone.0005933
23. C Li M Iida EF Dunn AJ Ghia DL Wheeler 2009 Nuclear EGFR contributes to acquired resistance to cetuximab Oncogene 28 43 3801 3813 19684613 10.1038/onc.2009.234 1:CAS:528:DC%2BD1MXpvFCrsLc%3D